Crispr Therapeutics put volume heavy and directionally bearish
The Fly

Crispr Therapeutics put volume heavy and directionally bearish

Bearish flow noted in Crispr Therapeutics with 2,199 puts trading, or 1.1x expected. Most active are Jan-25 40 puts and 1/5 weekly 65 calls, with total volume in those strikes near 2,200 contracts. The Put/Call Ratio is 1.69, while ATM IV is up over 1 point on the day. Earnings are expected on February 20th.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on CRSP:

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App